Cellyan Biotechnology Receives Nasdaq Bid Price Deficiency Notice, Faces Potential Delisting
HKPD sits 17% above its 52-week low of $0.68.
Summary
Cellyan Biotechnology Co., Ltd received a Nasdaq notification for failing to meet the minimum $1.00 bid price requirement, initiating a 180-day compliance period to avoid potential delisting.
Key Events · Corporate Governance and Compliance · HKPD
-
Nasdaq Bid Price Deficiency
The company was notified by Nasdaq that its Class A ordinary shares traded below the minimum $1.00 bid price for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2).
-
Compliance Period Initiated
Cellyan Biotechnology has 180 calendar days, until July 13, 2026, to regain compliance by having its closing bid price reach at least $1.00 for a minimum of ten consecutive business days.
-
Potential for Further Action
Failure to regain compliance within the initial period may lead to eligibility for an additional 180-day grace period, potentially requiring a reverse share split to meet the bid price requirement.
-
No Immediate Delisting
The notification does not result in immediate delisting, and the company's shares will continue to trade uninterrupted under the symbol "HKPD" during the compliance period.
Analysis · HKPD · Trade & Services
Cellyan Biotechnology Co., Ltd has received a formal notification from Nasdaq regarding its failure to meet the minimum $1.00 bid price requirement. This is a significant risk event for the company, as continued non-compliance could lead to delisting from the Nasdaq Capital Market. While there is a 180-day compliance period, and potentially an additional grace period, the company will need to take action, possibly including a reverse stock split, to maintain its listing. For a micro-cap company like Cellyan Biotechnology, maintaining a Nasdaq listing is crucial for liquidity and investor visibility, making this a very important development for shareholders.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 35.6% of the 1216 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HKPD was trading at $0.80 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $8.8M. The 52-week trading range was $0.68 to $3.20. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.